Vapotherm (NYSE:VAPO – Get Rating) had its target price cut by stock analysts at Canaccord Genuity Group from $21.00 to $12.00 in a research report issued on Wednesday, The Fly reports. Canaccord Genuity Group’s price objective indicates a potential upside of 92.93% from the company’s current price. VAPO has been the topic of a number […]
Vapotherm (NYSE:VAPO – Get Rating) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to an “underweight” rating in a note issued to investors on Thursday, The Fly reports. A number of other equities research analysts also recently issued reports on VAPO. Canaccord Genuity Group reduced their price target on shares of […]
Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company […]